A randomized, double-masked parallel-group, multicenter clinical study evaluating the efficacy and safety of the biosimilar candidate AVT06 compared to the reference product aflibercept in participants with neovascular age-related macular degeneratio

Authors

Silvia Cirillo (ORCID: https://orcid.org/0000-0003-1533-6247)
Steffen Leutz
Fausto Berti (ORCID: https://orcid.org/0000-0002-7684-1792)
Hansjürgen Agostini (ORCID: https://orcid.org/0000-0002-0331-1109)
Hendrik Otto
Abid Sattar
Kristīne Baumane (ORCID: https://orcid.org/0000-0002-7997-7249)
Vilma Jūratė Balčiūnienė (ORCID: https://orcid.org/0000-0001-6126-9351)
Masna Rai (ORCID: https://orcid.org/0000-0003-1760-6597)
Rajendra Kumar Soni (ORCID: https://orcid.org/0009-0009-2621-6671)
S. Hamdi
Kaspars Ozols

Institutions

University Medical Center Freiburg (DE)
Hospital of Lithuanian University of Health Sciences Kaunas Clinics (LT)
Riga East University Hospital (LV)
Alvotech (Germany) (DE)
Eye Center (SA)
Kursk Regional Clinical Oncology Center (RU)
SwissLitho (Switzerland) (CH)
Ophthalmology Clinic (DE)

Publication Details

Journal: Expert Opinion on Biological Therapy
Published: 2025-06-13
DOI: https://doi.org/10.1080/14712598.2025.2519531
Citations: 4
Primary Topic: Retinal Diseases and Treatments
Type: article
Field-Weighted Citation Impact: 6.83

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

A randomized, double-masked parallel-group, multicenter clinical study evaluating the efficacy and safety of the biosimilar candidate AVT06 compared to the reference product aflibercept in participants with neovascular age-related macular degeneratio

Silvia Cirillo, Steffen Leutz, Fausto Berti, Hansjürgen Agostini et al.

Jun 13, 2025

4 citations

Expert Opinion on Biological Therapy

Retinal Diseases and Treatments

6.83

article

A randomized, double-masked parallel-group, multicenter clinical study evaluating the efficacy and safety of the biosimilar candidate AVT06 compared to the reference product aflibercept in participants with neovascular age-related macular degeneratio

Silvia Cirillo, Steffen Leutz, Fausto Berti, Hansjürgen Agostini, Hendrik Otto, Abid Sattar, Kristīne Baumane, Vilma Jūratė Balčiūnienė, Masna Rai, Rajendra Kumar Soni, S. Hamdi, Kaspars Ozols

June 13, 2025article en

4 citations

Abstract

No abstract available for this paper.

Expert Opinion on Biological TherapyVol. 25(7)

University Medical Center Freiburg (DE), Hospital of Lithuanian University of Health Sciences Kaunas Clinics (LT), Riga East University Hospital (LV), Alvotech (Germany) (DE), Eye Center (SA), Kursk Regional Clinical Oncology Center (RU), SwissLitho (Switzerland) (CH), Ophthalmology Clinic (DE)

Openalex Percentile: Top 3%

Retinal Diseases and Treatments

6.83

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A randomized, double-masked parallel-group, multicenter clinical study evaluating the efficacy and safety of the biosimilar candidate AVT06 compared to the reference product aflibercept in participants with neovascular age-related macular degeneratio — Silvia Cirillo, Steffen Leutz, et al. · Expert Opinion on Biological Therapy (2025) | TGRS Research Map | TGRS